BIO vs TOL · rev $651.0M vs P/E 11, rev $7.34B
BIO (BIO) versus Toll Brothers Inc (TOL) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Toll Brothers Inc (TOL) is a residential construction company listed on NYSE.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported TOL revenue for 2026-07-31 was $7.34B. Net income was $751.7M. Revenue was up 56.8% from 2026-04-30 to 2026-07-31. TOL currently screens at market cap $13.99B and trailing P/E 11.4.
BIO currently screens at market cap $0. TOL currently screens at market cap $13.99B and trailing P/E 11.4.
Not investment advice. Open the BIO and TOL stock pages for the full models.
Not investment advice.